FDA Issues Updated Guidance for Convalescent Plasma, Outlines How Donors and Plasma Should Be Tested
Points of interest from the US Food and Drug Administration’s November 2020 update to investigational COVID-19 convalescent plasma guidelines.
Day: November 25, 2020